The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)
Completed · Phase 2 · Has a placebo group
Conditions studied: Nonproliferative Diabetic Retinopathy
In brief
The purpose of this study is to evaluate the safety and efficacy of subcutaneously administered AKB-9778 15mg once daily or 15mg twice daily for 12 months in patients with moderate to severe non-proliferative diabetic retinopathy (NPDR).
Key facts
- Study ID
- NCT03197870
- Run by
- EyePoint Pharmaceuticals, Inc.
- People needed
- 167
- Starts
- 2017-06-09
- Expected to finish
- 2019-02-09
- Last updated by the study team
- 2023-06-27
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Retinal Research Institute — Phoenix, Arizona, United States
- Retina Institute of California — Arcadia, California, United States
- California Retina Consultants — Bakersfield, California, United States
- Retina Vitreous Associates Medical Group — Beverly Hills, California, United States
- Retina Consultants of Orange County — Fullerton, California, United States
- Ophthalmic Clinical Trials San Diego — Oceanside, California, United States
- Stanford — Palo Alto, California, United States
- California Retina Consultants — Santa Barbara, California, United States
- California Retina Consultants — Santa Maria, California, United States
- Retina Consultants of Southern Colorado — Colorado Springs, Colorado, United States
- Colorado Retina Associates — Golden, Colorado, United States
- Rand Eye Institute — Deerfield Beach, Florida, United States
- Center for Retina and Macular Disease — Lakeland, Florida, United States
- Retina Specialty Institute — Pensacola, Florida, United States
- Southeast Retina Center — Augusta, Georgia, United States
- Georgia Retina — Marietta, Georgia, United States
- University Retina — Oak Forest, Illinois, United States
- Illinois Retina Associates — Oak Park, Illinois, United States
- Midwest Eye Institute — Indianapolis, Indiana, United States
- Wolfe Eye Clinic — West Des Moines, Iowa, United States
- Central Plains Eye MDs — Wichita, Kansas, United States
- Retina Associates of Kentucky — Lexington, Kentucky, United States
- Johns Hopkins University School of Medicine — Baltimore, Maryland, United States
- Cumberland Valley Retina Consultants PC — Hagerstown, Maryland, United States
- Arizona Retina and Vitreous Consultants — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.